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Visually-guided behavior recruits a network of brain regions so extensive that it is often affected by neuropsy-
chiatric disorders, producing measurable atypical oculomotor signatures. Wang et al. (2015) combine eye
tracking with computational attention models to decipher the neurobehavioral signature of autism.Imagine that you are waiting for a pre-
scription to be filled at your local phar-
macy. Today, many pharmacies in the
United States of America provide free
blood pressure monitors that you can
use as a rapid health indicator while you
wait. You simply place your arm in the
pressure band, press a button, and
observe the readings. If the readings are
high, it may be a good idea to check
with your doctor whether any corrective
action should be taken. What if similar
devices could be made available for the
evaluation of mental health?
Recent progress in eye-tracking tech-
niques is opening new avenues for quanti-
tative, objective, simple, inexpensive, and
rapid evaluation of mental health, as
shown in this issue by the study of Wang
et al. (2015). The starting premise is that
the visual attention and eye movement
networks are so pervasive in the human
brain (Corbetta and Shulman, 2002; Miller
and Buschman, 2013) that many neuro-
developmental and neurodegenerative
disorders may affect their functioning,
resulting in quantifiable alterations of
eye movement behavior (Leigh and Zee,
2015). Indeed, the control of attention
and gaze involves not only occipital (early
vision), temporal (high-level object vision),
parietal (spatial vision and attention), and
frontal (goal-driven vision) cortices, but
also the limbic system, reward systems,
and deep-brain nuclei including the
thalamus and the superior colliculus (Ba-
luch and Itti, 2011; Gottlieb et al., 2014)
(Figure 1A). Consequently, many previous
studies have demonstrated differences in
saccadic reaction time, in saccadeandfix-
ation metrics, and in error patterns during
visually-guided behavior, for a wide range442 Neuron 88, November 4, 2015 ª2015 Elsof neurobehavioral disorders. Most
studies to date have used structured labo-
ratory tasksandstimuli. Anotable example
is the anti-saccade task, where a periph-
eral target suddenly appears on a blank
screen and the task is to refrain from look-
ing at it, and to instead look in the opposite
direction where there is nothing on the
display (Munoz and Everling, 2004). Pa-
tients show either markedly slower reac-
tion times, increased error rates, or both,
compared to controls, as tested with
attention deficit hyperactivity disorder
(ADHD), Tourette’s syndrome,Parkinson’s
disease, and schizophrenia (Munoz and
Everling, 2004). The same eye movement
tasks canbe used tomonitor development
and maturation, even in control subjects
(Luna et al., 2008). This general approach
already provides a valuable complement
to more conventional neuropsychiatric
assessment usingquestionnaires andclin-
ical evaluations, especially for those disor-
ders for which a clear chemical, genetic,
morphological, physiological, or histologi-
cal biomarker has not yet been identified.
The study of Wang et al. (2015) focuses
on autism spectrum disorder (ASD) and
replaces structured tasks and laboratory
stimuli—previously extensively studied in
ASD (e.g., Takarae et al., 2004)—by sim-
ple free viewing of natural images. This
presents a number of advantages that
have recently been noted in the literature
(Tseng et al., 2013): the technique is appli-
cable to very young children or to any in-
dividual (or animal) who may not under-
stand or be interested in complying with
any task instruction, the stimuli present a
wider range of visual attributes (including
low-level features, such as many different
textures, colors, and shapes, but also, ofevier Inc.particular interest in Wang et al.’s study,
many different kinds of objects and
many different semantic valences of items
or actors in the scenes), and the amount
of information collected per unit time is
higher than for typical laboratory tasks
based on a trial-by-trial structure. But
this comes at the cost of significantly
complicating the ensuing data analysis.
Indeed, the inter-observer variability in
gaze patterns during free viewing of natu-
ral scenes is large even within control
populations (Mannan et al., 1995; also
note the spread of fixations for some stim-
uli in Figure 1 of Wang et al., 2015), the
stimuli are highly complex and cannot at
present be fully characterized or codified
by existing theories of object perception
or visual scene understanding; the open-
ended nature of the free-viewing task in-
vites further variability due to cultural,
gender, and other individual differences;
and eye movements are recorded on a
continuous basis as opposed to well-
defined, discrete trial-by-trial episodes.
As a result, while obvious differences
in fixation preferences may be notable
between patient and control groups on
some images (Figure 1 of Wang et al.,
2015), quantifying those differences in
terms of possible differences in attention
allocation toward different attributes of
the stimuli is not trivial. This is where
new computational models and machine
learning tools can help. Here, Wang
et al. (2015) develop an elegant three-
stage visual saliency model, which pro-
duces a topographic activation map for
each natural image in their stimulus set.
The map highlights locations in the image
that are more conspicuous and hence
more likely to be looked at, at least by
Figure 1. Brain Circuit of Attention and Behavioral Signatures of Disorders
(A)Signalsandbrain structures thathavebeen implicated inattentionandgazecontrol. Theflash symbol indicates that a structurehasbeenmicrostimulatedandanX
indicates that it has been lesioned in previous studies, to characterize its role in the circuit. The connections show the most likely type of signal being transmitted
between two structures; top-down ([TD]; goal driven) signals in blue, bottom-up ([BU]; stimulus driven) signals in red, andbidirectional signals in gray. Abbreviations:
SC, superior colliculus; SNr, substantia nigra pars reticulata; MD, mediodorsal thalamus; LGN, lateral geniculate nucleus; IT, inferotemporal cortex; MT, middle
temporal area; LIP, lateral intraparietal area; FEF, frontal eye fields; PFC, prefrontal cortex. Reproduced with permission from Baluch and Itti (2011).
(B) Signatures of three different disorders—ADHD and FASD in children, as well as Parkinson’s disease (PD) in elderly—obtained through eye tracking while
participants freely watched natural video clips. The signatures show strikingly distinct, quantitative, and objective patterns of atypical deployment of gaze, here
along 15 dimensions from three broad categories: oculomotor (saccade and fixation metrics), saliency based (attention to visual features of the stimuli), and
group-based (correlation with gaze patterns of control young adults). Such signature or behavioral biomarker can be computed for any new individual and then
classified using machine learning systems into the most likely patient or control group. Error bars indicate 95% confidence intervals after Bonferroni correction.
Significance level: p < 0.01, one-tailed paired t-test. Adapted from Tseng et al. (2013).
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typically constructed as the weighted
sum or aggregation of several feature
maps, each sensitive to a particular visual
attribute (e.g., color contrast or oriented
edges; Itti et al., 1998). Using a standard
machine learning system (support vector
machine [SVM]), Wang et al. (2015) learn
the relative weights of different features
that contribute to saliency so as to maxi-
mize the agreement between model sa-
liency maps and recorded human fixa-
tions, separately for the control and
patient groups. Differences in the learned
weights between patient and control
groups indicate different levels of prefer-
ence or different degrees of attractive-
ness of the features across the two
groups. Wang et al., 2015 (see Figure 2)
indeed report a striking set of differencesbetween ASD patients and controls:
model weights for ASD patients were
higher for pixel-level salience, for the
background of the scene, and for the im-
age center, but lower for objects and
items with semantic valence, such as
faces or items being looked at by persons
or animals in the scene. Repeating the
analysis for individual saccades as they
developed over the time spent scanning
an image revealed, for both groups, a
general decrease in the weights of low-
level features and an increase in weights
of object and semantic features (Figure 3
of Wang et al., 2015), suggesting a
progressively lower influence of image-
based or bottom-up features and higher
influence of top-down factors in guiding
gaze as time develops (as already noted
previously with simpler models; e.g., Par-Neuron 88,khurst et al., 2002). An interesting new
result is the relatively lower decrease
in weights for low-level features, and rela-
tively lower increase in weights for object-
level and semantic features, for ASD pa-
tients compared to controls (Figure 3 of
Wang et al., 2015). These differences in
model weights were corroborated in a
model-free analysis that demonstrated
fewer and slower saccades toward se-
mantic objects for the ASD group, more
fixations in the background, and longer
fixations over background and other ob-
jects (Figures 4D–4F of Wang et al.,
2015). Among the semantic features, mo-
tion, smell, and touch features had lower
model weights in ASD patients compared
to controls, as well as faces, for later fixa-
tions in the scanpaths (Figures 5 and S5E
of Wang et al., 2015). Finally, althoughNovember 4, 2015 ª2015 Elsevier Inc. 443
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tracted more fixations overall, there was
no difference between ASD and controls
in this dimension (Figure 6 of Wang
et al., 2015). Overall, the study reveals a
complex pattern of differences between
the ASD and control groups, with detailed
ramifications into the nature of the items
gazed at and the time at which they
were gazed at. Because it is complex,
this pattern may be viewed as lacking a
simple interpretation and may be difficult
to directly link to phenotype and underly-
ing neurophysiology. For example, it is
not true that ASD patients strongly
avoided human faces and locations
gazed at by humans or animals in the im-
ages, since the weights for these features
are non-zero and, overall, not significantly
lower for ASD patients than for controls
(Figure 5 ofWang et al., 2015). This makes
it difficult to directly translate the findings
into neurological terms or into an interpre-
tation of what functional brain mechanism
differences may exist between the patient
and control groups.
Yet, just because an elevated blood
pressure reading does not fully explain
what is abnormal in the circulatory system
does not render it useless, and likewise
with eye-trackingmeasures such as those
of Wang et al., 2015. Although complex
patterns of differences may not directly
pinpoint which brain areas or functions
are affected by a disease, they can be
used as characteristic behavioral bio-
markers—or behavioral biometric signa-
tures—of particular disorders. Such sig-
natures can support screening and
differentiations among patients, not only
at the level of group-based statistical ef-444 Neuron 88, November 4, 2015 ª2015 Elsfects (as shown by Wang et al., 2015),
but also possibly for individual persons.
For example, using a similar approach
but with video rather than static stimuli,
Tseng et al. (2013) were able to build a
three-way classifier that could differen-
tiate between children with ADHD, fetal
alcohol spectrumdisorder ([FASD], some-
times comorbid with ADHD), and controls,
well above chance, from eye movements
recorded over 15 min of watching televi-
sion (Figure 1B). Applying the same
methods but at the other end of the age
spectrum, the classifier was 90% correct
at differentiating Parkinson’s disease pa-
tients from elderly controls. Thus, a bright
future seems to lie ahead for approaches
like those described in this issue by
Wang et al., 2015. A key issue for the im-
mediate future is that these techniques
should be shown to be equally or more
sensitive and specific than existing ap-
proaches, for example through longitudi-
nal studies (Magiati et al., 2014) of large
cohorts of initially undiagnosed individ-
uals, some of whom may later develop a
disorder that had been predicted by the
model-based analysis. If that is the case,
maybe some day in the not so distant
future simple mental health assessment
machines based on eye tracking may
come to existence, possibly at your
nearby pharmacy (Tseng et al., 2014).ACKNOWLEDGMENTS
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